HTT and Huntington disease: By using an antibody which selectively binds to the toxic N-terminal fragment of the mutant HTT (EM48), they examined whether iPSC-derived neurons develop huntingtin aggregates, a neuropathological hallmark of HD, after differentiation or intracerebral transplantation.